INSIGHTS ON DRUG DEVELOPMENT

• The Top Tech Transfer Risks At Multi-Site CDMOs

  Many tech transfer risks are avoidable with a single campus CDMO. With all manufacturing facilities on one site, drug sponsors can overcome obstacles and maintain speed en route to market.

• A Simple And Powerful Solution For Accelerating Dissolution

  Many poorly soluble drugs fail not because of low solubility, but because they dissolve too slowly. Learn how focusing on dissolution rate can unlock absorption gains using simple strategies.

• How To Benchmark Your Digital Transformation Performance And AI-Readiness

  AI investment is rising across life sciences, but data challenges stall real-world adoption. Discover what is holding teams back and how to turn AI potential into practical scientific impact.

• High-Throughput 90-Minute ELISA

  Discover how one solution can be utilized to measure Human IgG and human IFN gamma, which are key targets in pharmacokinetic studies and immunotherapeutic drug safety testing, in just 90 minutes.

• A Case Study Of The GLP-1 Receptor Agonist, Semaglutide, In Plasma

  7/31/2025

  Light scattering reveals critical insights into the structural integrity, aggregation, and stability of GLP-1 analogs, which are essential for optimizing drug formulations and improving treatments.

• KORSCH Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And Packaging

  9/18/2025

  Simulate high-speed tablet production early in development with minimal material. Gain accurate scale-up, faster material characterization, and flexible formulation options—all with one compaction simulator.

• What Is DMPK, And Why Does It Matter In Drug Development?

  5/1/2025

  By leveraging advanced DMPK software solutions, you can streamline your workflows and make informed decisions with confidence.

• Imagine The Future: An Enhanced Oligonucleotide Synthesis Process

  2/9/2026

  Gain practical guidance for improving oligo quality, see how an advanced synthesis platform supports production, and explore a software interface designed to make daily operations more intuitive.

• Functional Characterization Of 3D Assembled Neurospheres

  4/4/2025

  Neural organoids and 3D spheroids offer advanced platforms for brain research and drug discovery. Discover how creating 3D neurospheres from iPSC-derived neurons and astrocytes aids in compound profiling and toxicity testing.